Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Not Confirmed
Not Confirmed
06-10 December, 2025
CPhI Middle EastCPhI Middle East
Not Confirmed
Not Confirmed
08-10 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Industry Trade Show
Not Confirmed
06-10 December, 2025
CPhI Middle EastCPhI Middle East
Industry Trade Show
Not Confirmed
08-10 December, 2025
Digital content

10 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/10/3184528/0/en/ArriVent-BioPharma-Reports-Third-Quarter-2025-Financial-Results.html

22 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/22/3154297/0/en/ArriVent-Appoints-Brent-S-Rice-as-Chief-Commercial-Officer.html

09 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/09/3146827/0/en/Arrivent-Presents-the-Final-Analysis-of-Firmonertinib-Monotherapy-Data-from-Global-Phase-1b-Study-in-EGFR-PACC-Mutant-Non-Small-Cell-Lung-Cancer-at-the-2025-World-Conference-on-Lun.html

11 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/11/3130840/0/en/ArriVent-BioPharma-Reports-Second-Quarter-2025-Financial-Results.html

21 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/21/3118677/0/en/ArriVent-s-Topline-Pivotal-Phase-3-FURVENT-Data-for-Firmonertinib-in-First-Line-NSCLC-EGFR-Exon20-Insertion-Mutations-is-Projected-to-be-Early-2026.html

01 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/02/3108879/0/en/ArriVent-Announces-Pricing-of-75-Million-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html
ABOUT THIS PAGE